Last reviewed · How we verify
NCT07247149
Testing a Novel Attention Based Training Prevention Strategy for First Responders: FirstFocus a Mobile App
NA trial testing Attention Bias Modification in Wellbeing in 80 participants. Enrolling by invitation.
1 September 2026
Quick facts
| Lead sponsor | Palo Alto University |
|---|---|
| Phase | NA |
| Status | ENROLLING BY INVITATION |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 80 |
| Start date | 15 November 2025 |
| Primary completion | 1 September 2026 |
| Estimated completion | 1 December 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Attention Bias Modification
Conditions studied
- Wellbeing — all drugs for Wellbeing →
Sponsor
Palo Alto University
Who can join
18 and older, any sex, with Wellbeing. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
First responders are frequently exposed to high-stress and traumatic events, putting them at increased risk for mental health challenges such as posttraumatic stress disorder, anxiety, and depression. Access to traditional mental health services is often hindered by stigma, time constraints, and a lack of tailored resources. Mobile app-based interventions offer a promising solution due to their accessibility and potential to address mental health proactively and in a time sensitive way. Attention training has emerged as a simple way to prevent distress and the emergence of future mental health concerns. The proposed research will test a mobile app: FirstFocus which will leverage targeted attention training to prevent stress/distress during shifts and enhance the wellbeing of rural first responders. The specific aims are to (1) test the feasibility and acceptability of FirstFocus as an intervention for rural first responders; (2) to test the short-term preventative efficacy of attention training on state stress/distress and its longer-term efficacy for improving professional quality of life and reducing symptoms of anxiety and depression.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07247149
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Attention Bias Modification
Trials testing the same drug.
- NCT06267313 — Attention Training for COVID-19 Related Distress · NA · terminated
- NCT05741684 — iCBT and ABM for Reducing Depressive Symptoms in Firefighters · NA · completed
- NCT05306197 — Improving Performance of Combat Soldiers by Utilizing Attentional Training Based on Eye Tracking · NA · terminated
- NCT05243459 — Testing the Efficacy of an Eye-tracking-based Treatment in Reducing Stress-related Symptoms in Veterans With PTSD · Phase 2, PHASE3 · terminated
- NCT05294848 — Increasing Psychological Resilience in Combat Soldiers Applying Advanced Eye-Tracking-Based Attention Bias Modification · NA · completed
Other recruiting trials for Wellbeing
Currently open trials in the same condition.
- NCT07494110 — Aurora: AI-Based Narrative Intervention to Support Emotional Well-Being in Clinical and Non-Clinical Populations · NA · recruiting
- NCT07480018 — Berberine Supplementation, Sprint Interval Training, and Immune Function Study · NA · recruiting
- NCT07361159 — Health and Wellness Coaching to Improve Thoracic Transplant Caregiver Self-Efficacy · NA · recruiting
- NCT07109050 — Virtual Reality Within Palliative Care (VR-SPC) · NA · recruiting
- NCT06871397 — Effectiveness of an Online Biopsychosocial Intervention to Improve Well-being and Mental Health During Pregnancy · NA · recruiting
Other Palo Alto University trials
Trials by the same sponsor.
- NCT07437872 — Testing Mechanisms of Virtual Reality Exposure Therapy for Social Anxiety · NA · recruiting
- NCT06409247 — iExposure Intervention for Social Anxiety · NA · active not recruiting
- NCT06267313 — Attention Training for COVID-19 Related Distress · NA · terminated
- NCT04230668 — Cognitive Processing Therapy (CPT) for Posttraumatic Stress Disorder and Borderline Personality Disorder (PTSD-BPD) · NA · unknown
- NCT05249582 — Virtual Reality Compared to Screen Based Engagement on Mood · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07247149 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Palo Alto University
- Last refreshed: 5 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07247149.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing